Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators
about
sameAs
Case-based study: from prediabetes to complications--opportunities for preventionESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryAssociation of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational studyBlood pressure control for diabetic retinopathyFirst-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertensionProstaglandin E1 for preventing the progression of diabetic kidney diseaseFirst-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertensionAntioxidant supplements for preventing gastrointestinal cancersAntioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesAngiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney diseaseAntioxidant supplements for preventing gastrointestinal cancersBlood pressure control for diabetic retinopathyStandards of medical care in diabetes--2012Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersImplications of recent hypertension trials for the generalist physician: whom do we treat, and how?Losartan and diabetic nephropathy: commentaries on the RENAAL studyIntimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.Neurohumoral stimulation in type-2-diabetes as an emerging disease conceptA novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on bloodDiabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trialsCardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-AnalysesMedical management of chronic stable anginaThe balance of powers: Redox regulation of fibrogenic pathways in kidney injuryThe effects of medicinal plants on renal function and blood pressure in diabetes mellitusDiabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survivalThe role of glucosamine-induced ER stress in diabetic atherogenesisAdipose tissue and adrenal glands: novel pathophysiological mechanisms and clinical applicationsBeat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agentsManaging hypertension in the elderly: a common chronic disease with increasing ageDiabetic kidney disease: a report from an ADA Consensus ConferenceModulation of glucose metabolism by the renin-angiotensin-aldosterone systemAdministration of Traditional Chinese Blood Circulation Activating Drugs for Microvascular Complications in Patients with Type 2 Diabetes MellitusClosing the knowledge gap on cardiovascular disease in type 2 diabetes: the EMPA-REG OUTCOME trial and beyondAn Overview of Plant Phenolic Compounds and Their Importance in Human Nutrition and Management of Type 2 DiabetesStatin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and ManagementManagement of diabetic nephropathyThe HOPE (Heart Outcomes Prevention Evaluation) Study and its consequencesHypertension in menopausal women--a special case, for special treatment?Diagnosis and management of the metabolic syndrome in obesityClinical impact of a pharmacist-managed diabetes mellitus drug therapy management service
P2860
Q21144738-340D659C-3615-436C-9EE1-6EB90C81F4F2Q22241786-EC088232-7FE0-4C4D-AFBB-7FA759932CD8Q22242096-EE3957B7-778B-4DA7-A7FF-9D195AEFAEEFQ24186434-671F6A92-6C16-4B13-88BB-9FE1369C1D5AQ24186647-04C350A1-06A1-49A2-AA4A-A2EFB19305BFQ24235251-A1A64552-E9C2-49A3-B880-9B071F67AFDFQ24240851-491E46D8-9C89-4561-84CA-E66AD91E2159Q24242191-B15A4309-1AF5-4193-97B3-CFBF33AC6732Q24242944-3BEFB46A-1493-4738-8DA9-5CA8393A37F1Q24244197-63693F14-77F0-40ED-B6C2-ACF430EDB05BQ24245704-5FC057D3-30D6-4A7D-9EA8-0B23D63E43F7Q24245872-39D63A7E-9D84-433A-8AF1-D018D9686D97Q24632533-76EA36A0-2A75-4894-8127-5DBA0DCA288FQ24644869-C4BAFF21-2433-4B80-923A-A2B38FB11A14Q24792362-C06104E0-9A18-4300-B5CD-83A1E902DF0DQ24796010-4099B57D-15BB-438C-A718-1F2AF169E57AQ24796491-78C74695-A7F4-412B-B364-271E99DE3CA3Q24798310-B50282C3-7BE0-4834-BA93-2EEE239126D1Q24806038-CAE4A506-6282-4380-975A-D4F484FD3E5DQ26766599-50821149-1BEE-4161-A5C1-ACF70397EB67Q26767278-EBE926FF-708A-43B7-941D-A29631627378Q26773268-FBE98FAB-B739-46D0-BD61-3F372471B9D9Q26786137-6DD493BE-1968-4700-AA93-E4CD93F6B9F8Q26822062-614AED7E-44AF-45AA-8AAE-DE04F3E2E995Q26827620-E98928B1-2736-4130-A244-055F08765BBDQ26830592-456E7FB8-58E2-41A3-AB63-0AE1513B73F3Q26860227-932878C0-925E-4729-BE75-4B8520D1D9CAQ27010669-A971382B-C3EE-42F3-B378-6E76C2246869Q27011805-C33A2118-B92B-484D-BFDC-683EC51D1CAEQ27012546-3843AF78-D453-4B73-B3EF-1E04A91913A0Q27026157-4E34BB5A-A0BA-4027-8C50-587EF127E2BDQ28072087-91FFF5B8-26CB-4923-86F8-584A1DCEFB7DQ28075848-7C2D778A-5793-4746-AF2F-08A28E9D5C25Q28078920-B4AEF891-8CDC-4A14-8B99-D4DE6D614768Q28083004-5A6B93BC-E40C-44FB-A041-C6D04D408717Q28184526-6918EA32-D425-4B04-9562-A469F1681705Q28188518-CBC38C77-8482-418B-953C-CC1D877D4462Q28191800-24CBC559-C3CE-4609-A907-7D15932CD7F3Q28192856-1BDAD79C-13E0-4A83-A231-010BF7CBA73AQ28194925-BABB768F-5F3C-4A9C-93E9-6A4FEF51C759
P2860
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Effects of ramipril on cardiov ...... Evaluation Study Investigators
@ast
Effects of ramipril on cardiov ...... Evaluation Study Investigators
@en
Effects of ramipril on cardiov ...... Evaluation Study Investigators
@nl
type
label
Effects of ramipril on cardiov ...... Evaluation Study Investigators
@ast
Effects of ramipril on cardiov ...... Evaluation Study Investigators
@en
Effects of ramipril on cardiov ...... Evaluation Study Investigators
@nl
altLabel
Effects of ramipril on cardiov ...... study and MICRO-HOPE substudy
@ast
Effects of ramipril on cardiov ...... study and MICRO-HOPE substudy
@en
prefLabel
Effects of ramipril on cardiov ...... Evaluation Study Investigators
@ast
Effects of ramipril on cardiov ...... Evaluation Study Investigators
@en
Effects of ramipril on cardiov ...... Evaluation Study Investigators
@nl
P3181
P1433
P1476
Effects of ramipril on cardiov ...... study and MICRO-HOPE substudy
@en
Effects of ramipril on cardiov ...... Evaluation Study Investigators
@en
P3181
P356
10.1016/S0140-6736(99)12323-7
P407
P577
2000-01-01T00:00:00Z
2000-01-22T00:00:00Z